Title : Gilead $1,100 a day drug. Now it will launch a generic at quarter the price
link : Gilead $1,100 a day drug. Now it will launch a generic at quarter the price
Gilead $1,100 a day drug. Now it will launch a generic at quarter the price
Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the priceBy Ron Leuty – Reporter, San Francisco Business Times
A generic version of Harvoni — one in a series of life-changing hepatitis C drugs Gilead Sciences Inc. introduced four years ago at a price of over $1,000 a pill — will hit the market early next year at a quarter the price of the branded drug.
But while lower-priced generics generally a problem for drug makers because they eat into revenue, Foster City-based Gilead (NASDAQ: GILD) is looking forward to the generic: It will keep control of the drug and expand its market.
The "authorized generics" of Harvoni and another Gilead hepatitis C drug, Epclusa, will be marketed under the flag of Asegua Therapeutics LLC, a new Gilead subsidiary.
Read more:
On This Blog
The controversy over expensive new drugs for hepatitis C
Link to a collection of current research articles regarding the effectiveness and safety of generic hepatitis C medicines. Read news articles addressing the high cost, insurance restrictions; private insurers/Medicaid and availability of generic versions/India, Egypt and other lower-income countries or through online "buyers clubs"
Thus Article Gilead $1,100 a day drug. Now it will launch a generic at quarter the price
That's an article Gilead $1,100 a day drug. Now it will launch a generic at quarter the price This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article Gilead $1,100 a day drug. Now it will launch a generic at quarter the price with the link address https://theleknews.blogspot.com/2018/10/gilead-1100-day-drug-now-it-will-launch.html
0 Response to "Gilead $1,100 a day drug. Now it will launch a generic at quarter the price"
Post a Comment